According to recent reports in the diabetes news, a diabetes drug currently used to lower blood sugar levels amongst people with diabetes could also be helpful to delay or prevent the disease amongst people predisposed to develop the condition. The results were uncovered by a study in Japa, published in The Lancet.
The generic drug voglibose could be used to treat pre-diabetes and metabolic syndromen, massive global problems that are reinforcing the type 2 diabetes epidemic. The team clearly showed how the drug could lower incidence of diabetes development .
The researchers reportedly commented: “Long term prophylaxis with this (drug) in high-risk individuals with impaired glucose tolerance could provide a pharmacological option, along with lifestyle modificatio, to help reduce the burden of type 2 diabetes in Japan.” The discovery could open up an important new treatment pathway to prevent people from developing type 2 diabetes at an earlier stage.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…